Prof. Yi-Long Wu: Patients on the afatinib arm had a significantly better quality of life ac-cording to the data of LUX-Lung 6

Posted On 2015-07-06 12:59:38

Professor Yi-Long Wu is a consultant oncologist, PhD supervisor, Fellow of American College of Surgeons, Vice President of GGH and Guangdong Academy of Medical Sciences as well as Director of Cancer Center, Director of Guangdong Lung Cancer Institute, member of the Council of the Chinese Anti-cancer Association, Chairman of the Chinese Society of Clinical On-cology (CSCO), Chairman of the Chinese Society of Lung Cancer (CSLC), President of Guang-dong Association of Clinical Trial.
Prof. Yi-Long Wu has been interviewed about his professional perspective in the field of LUX-Lung 6 in the 16th Annual Meeting of Chinese Society of Clinical Oncology (CSCO), which was held at Xiamen International Conference Center from Sept. 25 to 29, 2013.

Read More>>